[Ceftriaxone in the therapy of infections of the lower respiratory tract: comparison with cefotaxime]
- PMID: 3485265
[Ceftriaxone in the therapy of infections of the lower respiratory tract: comparison with cefotaxime]
Abstract
20 patients suffering from severe lower respiratory tract infections were included in the study. 10 patients were given ceftriaxone (1-2 g/day) and the other 10 cefotaxime (2-4 g/day) for a week. The results of microbiological findings and both local and systemic tolerance were found to be similar for both drugs. This indicates that 7-14 g of ceftriaxone and 14-28 g of cefotaxime are equivalent quantities in the treatment of severe respiratory tract infections.
Similar articles
-
Roxithromycin (RU 28965) in the treatment of respiratory tract infections.Chemioterapia. 1987 Feb;6(1):41-4. Chemioterapia. 1987. PMID: 3103931
-
Susceptibility patterns of bacterial isolates from hospitalised patients with respiratory tract infections (MOXIAKTIV Study).Int J Antimicrob Agents. 2009 Jan;33(1):52-7. doi: 10.1016/j.ijantimicag.2008.07.017. Epub 2008 Oct 1. Int J Antimicrob Agents. 2009. PMID: 18835763
-
In vitro activity of cefditoren and other antimicrobial agents against 288 Streptococcus pneumoniae and 220 Haemophilus influenzae clinical strains isolated in Zaragoza, Spain.Diagn Microbiol Infect Dis. 2008 Oct;62(2):210-5. doi: 10.1016/j.diagmicrobio.2008.06.007. Epub 2008 Aug 20. Diagn Microbiol Infect Dis. 2008. PMID: 18715733
-
Respiratory infections: clinical evaluation.Clin Ther. 1985;7 Suppl A:45-54. Clin Ther. 1985. PMID: 3907845 Review.
-
International experiences with ceftriaxone in the treatment of lower respiratory tract infections.Chemioterapia. 1987 Oct;6(5):364-73. Chemioterapia. 1987. PMID: 3322589 Review.
Cited by
-
Cefotaxime. An update of its pharmacology and therapeutic use.Drugs. 1990 Oct;40(4):608-51. doi: 10.2165/00003495-199040040-00008. Drugs. 1990. PMID: 2083516 Review.